GSK raises profit outlook on strong vaccine, HIV drug sales By Eva Mathews and Maggie Fick (Reuters) -GSK raised its full-year profit forecast on Wednesday on strong demand for its common respiratory vaccine and specialty HIV medicines, though it expects sales growth to slow in the second half. CEO Emma Walmsley’s strategy has focussed on […]
This post first appeared on Global Banking And Finance Review Magazine – Fin, please read the originial post: here
